Neurocognitive and motor deficits in HIV-infected ugandan children with high CD4 cell counts

Clinical Infectious Diseases

Volumn 54, Issue 7, 2012, Pages 1001-1009

  Ruel, Theodore D ^a   Boivin, Michael J ^b   Boal, Hannah E ^c   Bangirana, Paul ^d   Charlebois, Edwin ^e   Havlir, Diane V ^e   Rosenthal, Philip J ^e   Dorsey, Grant ^e   Achan, Jane ^f   Akello, Carolyne ^d   Kamya, Moses R ^d   Wong, Joseph K ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MAKERERE UNIVERSITY   (Uganda)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NONE   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPONSE TIME; SCHOOL CHILD; UGANDA; WORLD HEALTH ORGANIZATION;

AIDS DEMENTIA COMPLEX; CD4 LYMPHOCYTE COUNT; CHILD; FEMALE; HIV INFECTIONS; HUMANS; MALE; MOTOR NEURON DISEASE; PREVALENCE; UGANDA;

EID: 84858132621     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir1037     Document Type: Article

References (40)

1. Nozyce M, Hittelman J, Muenz L, Durako SJ, Fischer ML, Willoughby A. Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics 1994; 94:883-91. (Pubitemid 24359193)
2. Diamond GW, Kaufman J, Belman AL, Cohen L, Cohen HJ, Rubinstein A. Characterization of cognitive functioning in a subgroup of children with congenital HIV infection. Arch Clin Neuropsychol 1987; 2:245-56. (Pubitemid 17158741)
3. Belman AL, Diamond G, Dickson D, et al. Pediatric acquired immunodeficiency syndrome: neurologic syndromes. Am J Dis Child 1988; 142:29-35. (Pubitemid 18056357)
4. Cooper ER, Hanson C, Diaz C, et al. Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants Transmission Study Group. J Pediatr 1998; 132:808-12. (Pubitemid 28232931)
5. Brouwers P, Tudor-Williams G, DeCarli C, et al. Relation between stage of disease and neurobehavioral measures in children with symptomatic HIV disease. AIDS 1995; 9:713-20.
6. Msellati P, Lepage P, Hitimana DG, Van Goethem C, Van de Perre P, Dabis F. Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics 1993; 92:843-8. (Pubitemid 23351141)
7. Drotar D, Olness K, Wiznitzer M, et al. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics 1997; 100:E5.
8. McGrath N, Fawzi WW, Bellinger D, et al. The timing of motherto-child transmission of human immunodeficiency virus infection and the neurodevelopment of children in Tanzania. Pediatr Infect Dis J 2006; 25:47-52. (Pubitemid 43361476)
9. Van Rie A, Mupuala A, Dow A. Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo. Pediatrics 2008; 122:e123-8.
10. Boivin MJ, Green SD, Davies AG, Giordani B, Mokili JK, Cutting WA. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children. Health Psychol 1995; 14:13-21.
11. Bagenda D, Nassali A, Kalyesubula I, et al. Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviralnaive Ugandan children. Pediatrics 2006; 117:729-40. (Pubitemid 46063215)
12. Technical Reference Group on Paediatric HIV Care and Treatment. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Geneva: World Health Organization, 2006.
13. Kamya MR, Gasasira AF, Achan J, et al. Effects of trimethoprimsulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. AIDS 2007; 21:2059-66. (Pubitemid 47462155)
14. Boivin MJ, Ruel TD, Boal HE, et al. HIV subtype A is associated with poorer neuropsychological performance compared to subtype D in ART-naive Ugandan children. AIDS 2010; 24:1163-70.
15. Dorsey G, Staedke S, Clark TD, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA 2007; 297:2210-9.
16. Caldwell BM, Bradley RH. Home observation for measurement of the environment. Little Rock, AR: University of Arkansas Press, 1979.
17. Bangirana P, John CC, Idro R, et al. Socioeconomic predictors of cognition in Ugandan children: implications for community interventions. PLoS One 2009; 4:e7898, doi:10.1371/journal.pone.0007898.
18. Van Rie A, Dow A, Mupuala A, Stewart P. Neurodevelopmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of Congo. J Acquir Immune Defic Syndr 2009; 52:636-42.
19. Technical Reference Group on Paediatric HIV Care and Treatment. Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Recommendations for a public health approach: 2010 revision. World Health Organization, 2010.
20. CDC Growth Charts: United States. Vital Health Statistics of the Center for Disease Control and Prevention/National Center for Health Statistics 2000. Available at: www.cdc.gov/nchs/data/ad/ad314.pdf. Accessed 20 January 2012
21. Boivin MJ, Giordani B. Improvements in cognitive performance for schoolchildren in Zaire, Africa, following an iron supplement and treatment for intestinal parasites. J Pediatr Psychol 1993; 18:249-64. (Pubitemid 23146241)
22. Tardieu M. HIV-1 and the developing central nervous system. Dev Med Child Neurol 1998; 40:843-6. (Pubitemid 28561238)
23. Okamoto S, Kang YJ, Brechtel CW, et al. HIV/gp120 decreases adult neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal and G1 arrest. Cell Stem Cell 2007; 1:230-6. (Pubitemid 47215594)
24. Mishra M, Vetrivel S, Siddappa NB, Ranga U, Seth P. Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Ann Neurol 2008; 63:366-76. (Pubitemid 351499866)
25. Strain MC, Letendre S, Pillai SK, et al. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol 2005; 79:1772-88. (Pubitemid 40459123)
26. Pillai SK, Pond SL, Liu Y, et al. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain 2006; 129:1872-3.
27. Power C, McArthur JC, Johnson RT, et al. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 1994; 68:4643-9. (Pubitemid 24183062)
28. Dunfee RL, Thomas ER, Gorry PR, et al. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc Natl Acad Sci USA 2006; 103:15160-5. (Pubitemid 44583181)
29. Sacktor N, Nakasujja N, Skolasky RL, et al. HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 2009; 49:780-6.
30. Clifford DB, Mitike MT, Mekonnen Y, et al. Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J Neurovirol 2007; 13:67-72. (Pubitemid 46510146)
31. Ranga U, Shankarappa R, Siddappa NB, et al. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 2004; 78:2586-90. (Pubitemid 38228954)
32. Boivin MJ, Ruel TD, Boal HE, et al. HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS 2010; 24:1163-70.
33. Blanchette N, Smith ML, Fernandes-Penney A, King S, Read S. Cognitive and motor development in children with vertically transmitted HIV infection. Brain Cogn 2001; 46:50-3. (Pubitemid 32466573)
34. Boivin MJ, Bangirana P, Byarugaba J, et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics 2007; 119:e360-6. (Pubitemid 46397732)
35. Chiriboga CA, Fleishman S, Champion S, Gaye-Robinson L, Abrams EJ. Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART). J Pediatr 2005; 146:402-7. (Pubitemid 40347260)
36. Lindsey JC, Malee KM, Brouwers P, Hughes MD. Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy. Pediatrics 2007; 119: e681-93. (Pubitemid 46407543)
37. Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR 3rd. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS 2009; 23:1893-901.
38. Nozyce ML, Lee SS, Wiznia A, et al. A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics 2006; 117:763-70. (Pubitemid 46063218)
39. Puthanakit T, Vonthanak S, Ananworanich J, et al. Randomized clinical trial of immediate versus deferred antiretroviral therapy initiation in children older than one year with moderate immunodeficiency: the PREDICT Study (NCT00234091). In: International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. Rome, Italy, 2011: TULBPE023.
40. Smurzynski M, Wu K, Letendre S, et al. Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS 2011; 25:357-65.